In part 2 of our discussion on Alzheimer's diagnostics, our host, Jane Caldwell, speaks with Dr. Francesca De Simone. Dr. De Simone is Scientific Affairs Manager for Fujirebio Diagnostics and leads the company's neurodegenerative disease program. Dr. De Simone discusses the role of blood-based biomarkers for Alzheimer's disease in comparison to other forms of diagnostic tests, as well as her insights on the clinical needs for Alzheimer's and current progress in the field. Educational su...
All content for On Medical Grounds is the property of Medavera and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In part 2 of our discussion on Alzheimer's diagnostics, our host, Jane Caldwell, speaks with Dr. Francesca De Simone. Dr. De Simone is Scientific Affairs Manager for Fujirebio Diagnostics and leads the company's neurodegenerative disease program. Dr. De Simone discusses the role of blood-based biomarkers for Alzheimer's disease in comparison to other forms of diagnostic tests, as well as her insights on the clinical needs for Alzheimer's and current progress in the field. Educational su...
In the words of our host, Dr. Jane Caldwell, "If I were to choose two words to describe medicine in 2023, they would be REMOTE and FAST." New drugs to slow Alzheimer’s progression, mRNA technology used in cancer vaccines, rapid point-of-care molecular testing—tests which give results while the patient is still in the clinic, and diabetes medications turned into weight loss drugs. These are some of the topics we’ll be discussing today as the top medical stories of 2023. Visit us at OnMedicalG...
On Medical Grounds
In part 2 of our discussion on Alzheimer's diagnostics, our host, Jane Caldwell, speaks with Dr. Francesca De Simone. Dr. De Simone is Scientific Affairs Manager for Fujirebio Diagnostics and leads the company's neurodegenerative disease program. Dr. De Simone discusses the role of blood-based biomarkers for Alzheimer's disease in comparison to other forms of diagnostic tests, as well as her insights on the clinical needs for Alzheimer's and current progress in the field. Educational su...
